Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Terence W Friedlander"'
Autor:
Li Zhang, Lawrence Fong, David Y Oh, Eliezer Van Allen, Felix Y Feng, Anthony Wong, Eric J Small, Terence W Friedlander, Alec Starzinski, Zenghua Fan, Tony Li, Hewitt Chang, Marissa Gin, Katsuto Shinohara, Hao Nguyen, Caleb Hwang, Christopher De Leon, Rahul R Aggarwal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0340aac11ac1489581066e7c00216656
Autor:
Li Zhang, Divya Natesan, Lawrence Fong, Emily Chan, David Y Oh, Son Ho, Ivan de Kouchkovsky, Errol J Philip, Francis Wright, Daniel M Kim, Daniel Kwon, Hansen Ho, Sima P Porten, Anthony C Wong, Arpita Desai, Franklin W Huang, Jonathan Chou, Raj S Pruthi, Eric J Small, Terence W Friedlander, Vadim S Koshkin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Immune checkpoint inhibitors (ICI) can achieve durable responses in a subset of patients with locally advanced or metastatic urothelial carcinoma (aUC). The use of tumor genomic profiling in clinical practice may help suggest biomarkers to
Externí odkaz:
https://doaj.org/article/daffc1a2d771420089913bf03e6aaad2
Autor:
Padmanee Sharma, Sumit Subudhi, James P Allison, Rahul Aggarwal, Eric J Small, Terence W Friedlander, Brandon Chen, Jaqueline Marquez, Kate Allaire, Alexander Cheung, Sharon Ng, Christopher Nguyen, Matthew Spitzer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Sipuleucel-T is a US Food and Drug Administration-approved autologous cellular immunotherapy that improves survival in patients with metastatic castration-resistant prostate cancer (mCRPC). We examined whether administering ipilimumab afte
Externí odkaz:
https://doaj.org/article/10601fa611a047cb8c2b6cb57d7992a7
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187975 (2017)
Patients with muscle-invasive bladder cancer (MIBC) have poorer prognoses if cancer has metastasized to the lymph nodes. Genomic markers of lymph node involvement (LNI) would be useful for treatment planning, especially if measured at the biopsy stag
Externí odkaz:
https://doaj.org/article/d42b7b1d9ed04d0e9f14844576345676
Autor:
Clinton L. Cario, Emmalyn Chen, Lancelote Leong, Nima C. Emami, Karen Lopez, Imelda Tenggara, Jeffry P. Simko, Terence W. Friedlander, Patricia S. Li, Pamela L. Paris, Peter R. Carroll, John S. Witte
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Cell-free DNA’s (cfDNA) use as a biomarker in cancer is challenging due to genetic heterogeneity of malignancies and rarity of tumor-derived molecules. Here we describe and demonstrate a novel machine-learning guided panel desig
Externí odkaz:
https://doaj.org/article/4b8f1ffaa66a497293d31c9ad249bfe8
Publikováno v:
Advances in Oncology. 3:137-159
Autor:
Jonathan Chou, Kai Trepka, Martin Sjöström, Emily A. Egusa, Carissa E. Chu, Jun Zhu, Emily Chan, Ewan A. Gibb, Michelle L. Badura, Alberto Contreras-Sanz, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Yair Lotan, Peter C. Black, Sima P. Porten, Vadim S. Koshkin, Terence W. Friedlander, Felix Y. Feng
Publikováno v:
European Urology Oncology. 5:714-718
Sacituzumab govitecan (SG) is an antibody-drug conjugate (ADC) targeting TROP2, which has recently been approved for treatment-refractory metastatic urothelial cancer (UC). However, the variability of TROP2 expression across different bladder cancer
Autor:
Jason Zhu, Andrew J. Armstrong, Terence W. Friedlander, Won Kim, Sumanta K. Pal, Daniel J. George, Tian Zhang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Immune checkpoint inhibitors targeting the PD-1 pathway have greatly changed clinical management of metastatic urothelial carcinoma and metastatic renal cell carcinoma. However, response rates are low, and biomarkers are needed to predict fo
Externí odkaz:
https://doaj.org/article/60c2e401c65c4ce9b770b3cffe78bbfe
Autor:
Lawrence Fong, Eric J. Small, Peter R. Carroll, Jeffry P. Simko, Christopher Kane, Brian Rini, Terence W. Friedlander, Amy M. Lin, Charles J. Ryan, Matthew R. Cooperberg, Li Zhang, Vinh Dao, Jera Lewis, Serena Kwek, Stephen Chan, Xiao X. Wei
Granulocytic–macrophage colony-stimulating factor (GM-CSF) is used as an adjuvant in cancer vaccine trials and has the potential to enhance antitumor efficacy with immunotherapy; however, its immunologic effects are not fully understood. Here, we r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15b2dc3d6971176da657260486f22107
https://doi.org/10.1158/2326-6066.c.6548824.v1
https://doi.org/10.1158/2326-6066.c.6548824.v1
Autor:
Fred Saad, Juhui J. Jiao, Charlene Abrams, Caly Chien, Peter Hellemans, Margaret K. Yu, Terence W. Friedlander, Gerhardt Attard, Maja J.A. de Jonge, Ronald de Wit, Kim N. Chi, Edwin M. Posadas
Duration of treatment exposure and PSA response since start of therapy for patients receiving systemic therapy with an AR signaling inhibitor prior to study entry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6a97e106bd3776cad7573d26bf9aa2
https://doi.org/10.1158/1078-0432.22475339.v1
https://doi.org/10.1158/1078-0432.22475339.v1